Menu Search
Equities

Scotts Miracle-Gro Co

SMG:NYQ

Scotts Miracle-Gro Co

Actions
Basic MaterialsChemicals
  • Price (USD)72.75
  • Today's Change0.92 / 1.28%
  • Shares traded704.04k
  • 1 Year change+34.90%
  • Beta1.7401
Data delayed at least 15 minutes, as of Sep 19 2024 00:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 12-Sep-24
Select bar for recommendation details.
Recommendations12-Sep-24
Buy1
Outperform3
Hold5
Sell0
Strong Sell0

Share price forecast in USD

The 5 analysts offering 12 month price targets for Scotts Miracle-Gro Co have a median target of 80.00, with a high estimate of 85.00 and a low estimate of 65.00. The median estimate represents a 9.97% increase from the last price of 72.75.
High16.8%85.00
Med10.0%80.00
Low-10.7%65.00

Dividends in USD

In 2023, Scotts Miracle-Gro Co reported a dividend of 2.64 USD, equaling last years dividend. The 3 analysts covering the company expect dividends of 2.69 USD for the upcoming fiscal year, an increase of 1.78%.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in USD

On Jul 31, 2024, Scotts Miracle-Gro Co reported 3rd quarter 2024 earnings of 2.31 per share. This result exceeded the 1.93 consensus of the 8 analysts covering the company and exceeded last year's 3rd quarter results by 97.44%.
The next earnings announcement is expected on Nov 06, 2024.
Average growth rate+5.13%
Scotts Miracle-Gro Co reported annual 2023 earnings of 1.21 per share on Nov 01, 2023.
Average growth rate-9.15%
More ▼

Revenue history & estimates in USD

The Scotts Miracle-Gro Company had 3rd quarter 2024 revenues of 1.20bn. This bettered the 1.20bn consensus of the 7 analysts covering the company. This was 128.29% above the prior year's 3rd quarter results.
Average growth rate+48.39%
The Scotts Miracle-Gro Company had revenues for the full year 2023 of 3.55bn. This was 9.50% below the prior year's results.
Average growth rate+5.07%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.